Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126929241 | 12692924 | 1 | I | 20160630 | 20160817 | 20160829 | 20160829 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-069475 | BRISTOL MYERS SQUIBB | 76.36 | YR | M | Y | 0.00000 | 20160829 | CN | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126929241 | 12692924 | 1 | PS | METFORMIN HYDROCHLORIDE. | METFORMIN HYDROCHLORIDE | 1 | Oral | UNK | Y | 20357 | |||||||||
126929241 | 12692924 | 2 | SS | PREVISCAN /00261401/ | PENTOXIFYLLINE | 1 | Oral | 1.75 MG, QD | Y | 0 | 1.75 | MG | TABLET | QD | |||||
126929241 | 12692924 | 3 | SS | LISINOPRIL DIHYDRATE | LISINOPRIL | 1 | Oral | 1 DF, QD | Y | 0 | 1 | DF | QD | ||||||
126929241 | 12692924 | 4 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 1 DF, QD | Y | 0 | 1 | DF | QD | ||||||
126929241 | 12692924 | 5 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 1 DF, QD | Y | 0 | 1 | DF | QD | ||||||
126929241 | 12692924 | 6 | SS | OFLOCET /00731801/ | OFLOXACIN | 1 | Unknown | UNK | Y | 0 | |||||||||
126929241 | 12692924 | 7 | SS | AMAREL | GLIMEPIRIDE | 1 | Oral | 4 MG, QD | Y | 0 | 4 | MG | QD | ||||||
126929241 | 12692924 | 8 | SS | NEBIVOLOL. | NEBIVOLOL | 1 | Oral | 5 MG, QD | Y | 0 | 5 | MG | QD | ||||||
126929241 | 12692924 | 9 | C | ZOXAN /00639302/ | DOXAZOSIN MESYLATE | 1 | Unknown | 4 MG, UNK | U | 0 | 4 | MG | TABLET | ||||||
126929241 | 12692924 | 10 | C | AVODART | DUTASTERIDE | 1 | Unknown | 0.5 MG, UNK | U | 0 | .5 | MG | CAPSULE, SOFT |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126929241 | 12692924 | 1 | Diabetes mellitus |
126929241 | 12692924 | 2 | Product used for unknown indication |
126929241 | 12692924 | 3 | Hypertension |
126929241 | 12692924 | 4 | Cardiac failure |
126929241 | 12692924 | 6 | Urinary tract infection |
126929241 | 12692924 | 7 | Product used for unknown indication |
126929241 | 12692924 | 8 | Hypertension |
126929241 | 12692924 | 9 | Product used for unknown indication |
126929241 | 12692924 | 10 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126929241 | 12692924 | OT |
126929241 | 12692924 | LT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126929241 | 12692924 | Acute kidney injury | |
126929241 | 12692924 | Hyperkalaemia | |
126929241 | 12692924 | Hyponatraemia | |
126929241 | 12692924 | Metabolic acidosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126929241 | 12692924 | 1 | 20160630 | 0 | ||
126929241 | 12692924 | 2 | 20160630 | 0 | ||
126929241 | 12692924 | 3 | 20160630 | 0 | ||
126929241 | 12692924 | 4 | 20160630 | 0 | ||
126929241 | 12692924 | 5 | 20160630 | 0 | ||
126929241 | 12692924 | 6 | 201606 | 20160630 | 0 | |
126929241 | 12692924 | 7 | 20160630 | 0 | ||
126929241 | 12692924 | 8 | 20160630 | 0 |